Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Myriad Genetics, Inc. | MYGN | 5.74M | $32.75M |
BioMarin Pharmaceutical Inc. | BMRN | 6.03M | $344.75M |
Nurix Therapeutics, Inc. | NRIX | 8.05M | $195.29M |
BioCryst Pharmaceuticals, Inc. | BCRX | 8.3M | $83M |